CNS Pharmaceuticals Inc. (NASDAQ: CNSP) stock jumped 5.29% on Wednesday to $1.99 against a previous-day closing price of $1.89. With 0.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.53 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.0399 whereas the lowest price it dropped to was $1.8001. The 52-week range on CNSP shows that it touched its highest point at $11.30 and its lowest point at $0.61 during that stretch. Beta for the stock currently stands at 1.14.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CNSP was up-trending over the past week, with a rise of 55.47%, but this was up by 11.80% over a month. Three-month performance surged to 25.16% while six-month performance fell -67.95%. The stock lost -76.81% in the past year, while it has lost -17.08% so far this year.
Float and Shares Shorts:
At present, 1.91 million CNSP shares are outstanding with a float of 1.04 million shares on hand for trading. On May 14, 2023, short shares totaled 0.12 million, which was 2.89% higher than short shares on Apr 13, 2023. In addition to Mr. John Michael Climaco Esq., J.D. as the firm’s CEO, Pres & Director, Mr. Christopher S. Downs CPA, CTP, FP&A serves as its Chief Financial Officer.
Through their ownership of 6.26% of CNSP’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 8.34% of CNSP, in contrast to 2.84% held by mutual funds. Shares owned by individuals account for 0.19%. As the largest shareholder in CNSP with 5.57% of the stake, Armistice Capital LLC holds 124,000 shares worth 124,000. A second-largest stockholder of CNSP, Renaissance Technologies LLC, holds 26,800 shares, controlling over 1.20% of the firm’s shares. Citadel Securities LLC is the third largest shareholder in CNSP, holding 13,196 shares or 0.59% stake. With a 0.10% stake in CNSP, the Fidelity Extended Market Index Fu is the largest stakeholder. A total of 2,168 shares are owned by the mutual fund manager. The Fidelity Nasdaq Composite Index F, which owns about 0.06% of CNSP stock, is the second-largest Mutual Fund holder. It holds 1,358 shares valued at 2051.0. Fidelity Series Total Market Inde holds 0.03% of the stake in CNSP, owning 756 shares worth 1142.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, CNSP reported revenue of $0.00 and operating income of -$3.56M. The EBITDA in the recently reported quarter was -$3.56M and diluted EPS was -$2.70.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CNSP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CNSP analysts setting a high price target of $30.00 and a low target of $30.00, the average target price over the next 12 months is $30.00. Based on these targets, CNSP could surge 1407.54% to reach the target high and rise by 1407.54% to reach the target low. Reaching the average price target will result in a growth of 1407.54% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded CNSP stock several times over the past three months with 6 Buys and 0 Sells. In these transactions, 29,544 shares were bought while 0 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 29,544 while 0 shares were sold.